What's new

Human medicines European public assessment report (EPAR): Entecavir Viatris (previously Entecavir Mylan), entecavir, Date of authorisation: 18/09/2017, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Entecavir Viatris (previously Entecavir Mylan), entecavir, Date of authorisation: 18/09/2017, Revision: 9, Status: Authorised

Mar 10, 2025 - 11:59
 0
Human medicines European public assessment report (EPAR): Entecavir Viatris (previously Entecavir Mylan), entecavir, Date of authorisation: 18/09/2017, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Entecavir Viatris (previously Entecavir Mylan), entecavir, Date of authorisation: 18/09/2017, Revision: 9, Status: Authorised
Read More

Tags:

Previous Article

European Shortages Monitoring Platform (ESMP) User guide for national competent ...

Next Article

European Shortages Monitoring Platform (ESMP) User guide for marketing authorisa...

Related Posts

Generic and hybrid applications

Generic and hybrid applications

Feb 19, 2025  0

Human medicines European public assessment report (EPAR): Actelsar HCT, telmisartan,hydrochlorothiazide, Date of authorisation: 13/03/2013, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 12, 2025  0

Human medicines European public assessment report (EPAR): Leqembi, Lecanemab, Status: Opinion

Human medicines European public assessment report (EPAR...

Feb 28, 2025  0